These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 32103345)

  • 21. CGRP receptor antagonism and migraine therapy.
    Edvinsson L; Warfvinge K
    Curr Protein Pept Sci; 2013 Aug; 14(5):386-92. PubMed ID: 23745702
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methylprednisolone blocks interleukin 1 beta induced calcitonin gene related peptide release in trigeminal ganglia cells.
    Neeb L; Hellen P; Hoffmann J; Dirnagl U; Reuter U
    J Headache Pain; 2016; 17():19. PubMed ID: 26931452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Developments in targeting calcitonin gene-related peptide.
    Alabbad S; Figueredo N; Yuan H; Silberstein S
    Expert Rev Neurother; 2024 May; 24(5):477-485. PubMed ID: 38557226
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression and function of calcitonin gene-related peptide (CGRP) receptors in trigeminal ganglia of R192Q Cacna1a knock-in mice.
    Vilotti S; Vana N; Van den Maagdenberg AM; Nistri A
    Neurosci Lett; 2016 May; 620():104-10. PubMed ID: 27021026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Calcitonin gene-related peptide antagonists as treatments of migraine and other primary headaches.
    Goadsby PJ
    Drugs; 2005; 65(18):2557-67. PubMed ID: 16392873
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Calcitonin gene-related peptide antagonism and cluster headache: an emerging new treatment.
    Ashina H; Newman L; Ashina S
    Neurol Sci; 2017 Dec; 38(12):2089-2093. PubMed ID: 28856479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of Infusion of Calcitonin Gene-Related Peptide on Cluster Headache Attacks: A Randomized Clinical Trial.
    Vollesen ALH; Snoer A; Beske RP; Guo S; Hoffmann J; Jensen RH; Ashina M
    JAMA Neurol; 2018 Oct; 75(10):1187-1197. PubMed ID: 29987329
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Calcitonin Gene-Related Peptide-Targeted Therapies for Migraine and Cluster Headache: A Review.
    Schuster NM; Rapoport AM
    Clin Neuropharmacol; 2017; 40(4):169-174. PubMed ID: 28644160
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trigeminovascular calcitonin gene-related peptide function in Cacna1a R192Q-mutated knock-in mice.
    Chan KY; Labastida-Ramírez A; Ramírez-Rosas MB; Labruijere S; Garrelds IM; Danser AH; van den Maagdenberg AM; MaassenVanDenBrink A
    J Cereb Blood Flow Metab; 2019 Apr; 39(4):718-729. PubMed ID: 28792272
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of the non-peptide CGRP receptor antagonist BIBN4096BS in blocking CGRP-induced dilations in human and bovine cerebral arteries: potential implications in acute migraine treatment.
    Moreno MJ; Abounader R; Hébert E; Doods H; Hamel E
    Neuropharmacology; 2002 Mar; 42(4):568-76. PubMed ID: 11955527
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sex differences in behavior and expression of CGRP-related genes in a rodent model of chronic migraine.
    Stucky NL; Gregory E; Winter MK; He YY; Hamilton ES; McCarson KE; Berman NE
    Headache; 2011 May; 51(5):674-92. PubMed ID: 21521205
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recognizing the role of CGRP and CGRP receptors in migraine and its treatment.
    Edvinsson L; Warfvinge K
    Cephalalgia; 2019 Mar; 39(3):366-373. PubMed ID: 29020807
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in calcitonin gene-related peptide (CGRP) receptor component and nitric oxide receptor (sGC) immunoreactivity in rat trigeminal ganglion following glyceroltrinitrate pretreatment.
    Seiler K; Nusser JI; Lennerz JK; Neuhuber WL; Messlinger K
    J Headache Pain; 2013 Sep; 14(1):74. PubMed ID: 24004534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CGRP mechanism antagonists and migraine management.
    Karsan N; Goadsby PJ
    Curr Neurol Neurosci Rep; 2015 May; 15(5):25. PubMed ID: 25790955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CGRP receptors in the control of pain and inflammation.
    Benemei S; Nicoletti P; Capone JG; Geppetti P
    Curr Opin Pharmacol; 2009 Feb; 9(1):9-14. PubMed ID: 19157980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated levels of calcitonin gene-related peptide in upper spinal cord promotes sensitization of primary trigeminal nociceptive neurons.
    Cornelison LE; Hawkins JL; Durham PL
    Neuroscience; 2016 Dec; 339():491-501. PubMed ID: 27746346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuropeptides in migraine and cluster headache.
    Edvinsson L; Goadsby PJ
    Cephalalgia; 1994 Oct; 14(5):320-7. PubMed ID: 7828188
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Migraine and cluster headache - the common link.
    Vollesen AL; Benemei S; Cortese F; Labastida-Ramírez A; Marchese F; Pellesi L; Romoli M; Ashina M; Lampl C;
    J Headache Pain; 2018 Sep; 19(1):89. PubMed ID: 30242519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Calcitonin Gene-Related Peptide Modulators - The History and Renaissance of a New Migraine Drug Class.
    Hargreaves R; Olesen J
    Headache; 2019 Jun; 59(6):951-970. PubMed ID: 31020659
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calcitonin gene-related peptide and its role in migraine pathophysiology.
    Arulmani U; Maassenvandenbrink A; Villalón CM; Saxena PR
    Eur J Pharmacol; 2004 Oct; 500(1-3):315-30. PubMed ID: 15464043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.